Document Detail

Acute coronary syndromes: advances in antithrombotics.
MedLine Citation:
PMID:  23456409     Owner:  NLM     Status:  In-Data-Review    
Contemporary management of acute coronary syndromes (ACS) has evolved to include rapid revascularization, potent antithrombotic, and antiplatelets, all of which reduce the risk of ischemic complications. Despite these advances, recurrent ischemic and bleeding event rates are still substantial. This increased risk post-percutaneous coronary intervention (PCI) has been the seminal event leading to recent clinical trials evaluating more potent antiplatelet drugs (prasugrel, ticagrelor, and protease-activated receptor-1 [PAR-1] inhibitors) and novel oral anticoagulants (NOAC). Ideally, an effective anticoagulation regimen adequately reduces the incidence of recurrent ischemia and limits iatrogenic bleeding. In this review, we will discuss the advances in ACS pharmacotherapy, review the recent trials evaluating these drugs, and discuss the major dilemmas in interpreting and implementing their findings.
Nilusha Gukathasan; Roxana Mehran
Related Documents :
23067909 - A 2-hour thrombolysis in myocardial infarction score outperforms other risk stratificat...
1713999 - Effects of intracoronary gallopamil on coronary hemodynamics and myocardial oxygen cons...
316959 - Enflurane in patients with coronary artery disease.
24460809 - Very early recurrence of takotsubo syndrome.
23456409 - Acute coronary syndromes: advances in antithrombotics.
24958049 - Staged left ventricular recruitment and biventricular conversion in hypoplastic left he...
21949529 - Thrombophilia, left ventricular dysfunction and intracardiac thrombi in children.
17700279 - Mr-relaxometry of myocardial tissue: significant elevation of t1 and t2 relaxation time...
20529589 - Sevoflurane postconditioning protects isolated rat hearts against ischemia-reperfusion ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Current atherosclerosis reports     Volume:  15     ISSN:  1534-6242     ISO Abbreviation:  Curr Atheroscler Rep     Publication Date:  2013 Apr 
Date Detail:
Created Date:  2013-03-04     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100897685     Medline TA:  Curr Atheroscler Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  318     Citation Subset:  IM    
The Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Implementing standardized intravenous antibiotic desensitizations among hospital inpatients.
Next Document:  Fragile visual short-term memory is an object-based and location-specific store.